The role of irinotecan-bevacizumab as rescue regimen in children with low-grade gliomas: a retrospective nationwide study in 72 patients.

Charles de MarcellusArnault Tauziède-EspariatAurélie CuinetClaudia PasqualiniMatthieu P RobertKevin BeccariaStéphanie PugetNathalie BoddaertDominique Figarella-BrangerEmilie De CarliFranck BourdeautPierre LeblondFanny FouyssacNicolas AndreAnne I BertozziThibaut ButelChristelle DufourDominique Valteau-CouanetPascale VarletJacques Grill

Published in: Journal of neuro-oncology (2022)

Bevacizumab-irinotecan has the potential of disease control clinically and radiographically in children with recurrent LGG whatever their previous characteristics; in many cases however these responses are not sustained, especially in younger children.

Keyphrases

low grade
high grade
young adults
end stage renal disease
ejection fraction
newly diagnosed
peritoneal dialysis
risk assessment
climate change